Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsModerna...says its coronavirus vaccine trial produced 'robust' immune response
Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced robust immune responsehttps://www.cnbc.com/2020/07/14/moderna-says-its-coronavirus-vaccine-trial-produced-robust-immune-response-in-all-patients.html
Modernas shares soared after the company said its potential vaccine to prevent Covid-19 produced a robust immune response in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.
Modernas stock rose more than 16% in after-hours trading on the news.
All 45 patients produced neutralizing antibodies, which scientists believe is important for building immunity and provided more promising data that the vaccine may give some protection against the coronavirus. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine.
After two vaccinations, the vaccine elicited a robust immune response in all participants in all dose cohorts, Moderna said. The company said the levels of neutralizing antibodies in patients in the high dose group were fourfold higher than in recovered Covid-19 patients.
These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study, Modernas chief medical officer, Tal Zaks, said in a statement. We look forward to beginning our Phase 3 study of mRNA-1273 this month to demonstrate our vaccines ability to significantly reduce the risk of COVID-19 disease.
*snip*
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
8 replies, 700 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (3)
ReplyReply to this post
8 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Moderna...says its coronavirus vaccine trial produced 'robust' immune response (Original Post)
Nevilledog
Jul 2020
OP
It my understanding that he mRNA vaccines work to give longer lived immunity
Thekaspervote
Jul 2020
#5
When a story begins "Moderna's shares soared after the company said...," I think pump & dump
PSPS
Jul 2020
#6
Tried to get that in the title but too long. That's why I put full title in post.
Nevilledog
Jul 2020
#7
RT Atlanta
(2,517 posts)1. politics aside
whatever is going to be promising, clinically tested, with verifiable results, I am all for it.
here's to hoping some of these trials advance to something meaningful that will save lives.
SoonerPride
(12,286 posts)2. Encouraging news. I hope those antibodies last
My fear is that they fade after 8 weeks or so.
triron
(22,006 posts)4. It's T cells that last. I think.
LonePirate
(13,424 posts)3. This is good news. The question now is how long the immune response lasts.
Does the response last for a few weeks? A few months? A year? Longer? Basically, will the vaccine be something most people take once, like the MMR shot? Or will we need to receive yearly (or bi-yearly) vaccinations?
Thekaspervote
(32,774 posts)5. It my understanding that he mRNA vaccines work to give longer lived immunity
The m standing for memory, i.e. the virus is recognized longer as an invader and an attack is launched to stop it
PSPS
(13,601 posts)6. When a story begins "Moderna's shares soared after the company said...," I think pump & dump
Nevilledog
(51,120 posts)7. Tried to get that in the title but too long. That's why I put full title in post.
It always feels skeevy talking about stock prices for developing a vaccine for a pandemic.
Initech
(100,080 posts)8. This is definitely good news.
Now we need to see how long the immune response lasts before we can pop the champagne.